ヨーロッパの分子診断市場 – 業界動向と2028年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパの分子診断市場 – 業界動向と2028年までの予測

  • Healthcare
  • Published Report
  • Aug 2021
  • Europe
  • 350 ページ
  • テーブル数: 243
  • 図の数: 23

ヨーロッパの分子診断市場、製品別(試薬とキット、機器とサービスとソフトウェア)、技術別(質量分析(MS)、キャピラリー電気泳動、次世代シーケンシング(NGS)、チップとマイクロアレイ、ポリメラーゼ連鎖反応(PCR)ベースの方法、細胞遺伝学、in situハイブリダイゼーション(ISHまたはFISH)、分子イメージングなど)、アプリケーション別(腫瘍学、薬理ゲノム学、微生物学、出生前検査、組織タイピング、血液スクリーニング、心血管疾患、神経疾患、感染症など)、エンドユーザー別(病院、臨床検査室、学術機関)、国別(ドイツ、フランス、スペイン、トルコ、英国、オランダ、ロシア、スイス、ベルギー、イタリア、その他のヨーロッパ諸国)業界動向と2028年までの予測。

欧州の分子診断市場市場分析と洞察: ヨーロッパの分子診断市場

分子診断市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に5.5%のCAGRで成長し、2028年までに136億3,722万米ドルに達すると分析しています。感染症やがんの罹患率の増加により、分子診断市場の成長が促進されると予想されています。

分子診断は、組織または体液中の DNA、RNA、タンパク質などの分子を研究することで、感染症、遺伝性疾患、心血管疾患、神経疾患などの疾患を特定または診断します。PCR、質量分析、第 2 世代シーケンシング、細胞遺伝学、in situ ハイブリダイゼーション、分子イメージングなどのさまざまな技術が、さまざまな疾患の診断に使用されます。

COVID-19 を診断するための分子診断ツールの需要の高まりは、分子診断市場の成長を後押しすると予想されます。機器の高コストは、分子診断市場の成長に対する大きな制約となることが予想されます。高齢者人口の増加は、分子診断市場の成長の機会となることが予想されます。市場プレーヤー間の激しい競争は、分子診断市場の成長に対する課題となることが予想されます。

分子診断市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と分子診断市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

欧州の分子診断市場分子診断市場の範囲と市場規模

分子診断市場は、製品、技術、アプリケーション、エンドユーザーに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コアアプリケーション領域とターゲット市場の違いを判断するのに役立ちます。

  • 製品に基づいて、分子診断市場は試薬とキット、機器、サービスとソフトウェアに分類されます。2021年には、感染症やがんなどの病気を診断するための高度な技術に対する需要の高まりにより、機器セグメントが分子診断市場を支配すると予想されます。
  • 技術に基づいて、分子診断市場は、質量分析(MS)、キャピラリー電気泳動、次世代シーケンシング(NGS)、チップとマイクロアレイ、ポリメラーゼ連鎖反応(PCR)ベースの方法、細胞遺伝学、in situハイブリダイゼーション(ISHまたはFISH)、分子イメージングなどに分類されます。2021年には、COVID-19を診断し、パンデミックを抑制するためのPCRキットの需要増加により、ポリメラーゼ連鎖反応(PCR)ベースの方法セグメントが分子診断市場を支配すると予想されます。
  • 用途に基づいて、分子診断市場は、腫瘍学、薬理ゲノミクス、微生物学、出生前検査、組織タイピング、血液スクリーニング、心血管疾患、神経疾患、感染症などに分類されます。 2021年には、インフルエンザ、COVID-19、エイズなどの感染症の増加と、高効率の分子診断技術に対する需要の増加により、感染症セグメントが分子診断市場を支配すると予想されます。
  • エンドユーザーに基づいて、分子診断市場は病院、臨床検査室、学術機関に分類されます。2021年には、さまざまな病気の患者数の増加と診断機器の需要の高まりにより、臨床検査室セグメントが分子診断市場を支配すると予想されます。

ヨーロッパの分子診断市場の国別分析

ヨーロッパの分子診断市場が分析され、市場規模の情報は、上記のように国、製品、技術、アプリケーション、エンドユーザー別に提供されます。

ヨーロッパの分子診断市場レポートで取り上げられている国は、ドイツ、フランス、スペイン、トルコ、イギリス、オランダ、ロシア、スイス、ベルギー、イタリア、およびその他のヨーロッパ諸国です。

ドイツ地域の製品セグメントは、COVID-19患者やその他の心血管疾患、感染症などを診断するための診断機器の需要増加により、2021年から2028年の予測期間に最高の成長率で成長すると予想されています。ベルギーの製品セグメントは、医療費の増加により、ヨーロッパの分子診断市場を支配しています。英国は、ポイントオブケア検査と精密医療の需要増加により、リスクセグメントのヨーロッパの分子診断市場の成長をリードしています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

分子診断の認知度を高めるための主要市場プレーヤーによる戦略的活動の拡大が分子診断市場の成長を後押ししている  

分子診断市場では、分子診断市場における各国の成長に関する詳細な市場分析も提供しています。さらに、分子診断市場のプレーヤーの戦略と地理的なプレゼンスに関する詳細情報も提供しています。データは、2010 年から 2019 年までの履歴期間について利用可能です。

競争環境と分子診断市場シェア分析

分子診断市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、ヨーロッパの分子診断市場に関連する会社の焦点にのみ関連しています。

ヨーロッパの分子診断市場レポートを扱っている主要企業には、Abbott、Siemens Healthcare GmbH、Thermo Fisher Scientific Inc.、BD、bioMérieux SA、Cepheid、Hologic, Inc.、Myriad Genetics, Inc.、QIAGEN、Agilent Technologies, Inc.、Quidel Corporation、Beckman Coulter, Inc.、Bio-Rad Laboratories, Inc.、Illumina, Inc.、IMMUCOR、Luminex Corporation、Meridian Bioscience、F Hoffmann-La Roche Ltd、GenMark Diagnostics, Inc. など、国内企業が含まれます。DBMR アナリストは、競争力を理解し、各競合他社の競合分析を個別に提供します。

世界中の企業によって多くの契約、合意、発売も開始されており、分子診断市場の拡大を加速させています。

例えば、

  • 2021 年 6 月、サーモフィッシャーサイエンティフィック社は、高速カメラによる強化されたイメージングと音響フォーカスを提供する蛍光フローサイトメーター「Attune CytPix」という新製品を発売しました。

市場プレーヤーによるコラボレーション、製品の発売、事業拡大、受賞と表彰、合弁事業、その他の戦略により、分子診断市場における企業の足跡が強化され、組織の利益成長にも利益がもたらされます。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE MOLECULAR DIAGNOSTICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PRODUCT AND BRAND ANALYSIS: EUROPE MOLECULAR DIAGNOSTICS MARKET

4.2 ROLE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN EUROPE MOLECULAR DIAGNOSTICS MARKET

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING DEMAND FOR MOLECULAR DIAGNOSTIC TOOLS TO DIAGNOSE COVID-19

5.1.2 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER

5.1.3 RISING FUNDING FOR MOLECULAR DIAGNOSIS PRODUCTS

5.1.4 RISING DEMAND FOR POINT-OF-CARE (POC) TESTING

5.1.5 DEVELOPMENT OF COMPANION DIAGNOSTIC ASSAY AND PERSONALIZED MEDICINES

5.2 RESTRAINTS

5.2.1 HIGH COST OF INSTRUMENTATIONS

5.2.2 STRINGENT LEGAL AND REGULATORY STANDARDS ARE EXPECTED TO HAMPER THE MARKET GROWTH

5.2.3 DELAY IN APPROVAL OF EXPERIMENTAL TEST FOR MOLECULAR DIAGNOSIS

5.3 OPPORTUNITIES

5.3.1 RISING GERIATRIC POPULATION

5.3.2 INCREASING ADOPTION OF ANALYSER SOFTWARE FOR MOLECULAR DIAGNOSIS

5.3.3 RISING AWARENESS REGARDING RAPID TECHNOLOGICAL ADVANCEMENTS

5.3.4 RISING HEALTHCARE EXPENDITURE IN DEVELOPING REGION

1.4 CHALLENGES

5.3.5 HIGH COMPETITION AMONG MARKET PLAYERS

5.3.6 DISTURBED SUPPLY CHAIN DUE TO COVID-19

6 IMPACT OF COVID-19 ON THE EUROPE MOLECULAR DIAGNOSTICS MARKET

6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE EUROPE MOLECULAR DIAGNOSTICS MARKET

6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVES FOR GROWTH OF THE MOLECULAR DIAGNOSTICS MARKET

6.3 IMPACT ON DEMAND

6.4 IMPACT ON SUPPLY CHAIN

6.5 IMPACT ON PRICE

6.6 STRATEGIC INITIATIVES BY MANUFACTURERS

6.7 THE RISING COVID-19 CASES IS LEADING THE MOLECULAR DIAGNOSTICS MARKET

6.8 CONCLUSION

7 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 INSTRUMENTS

7.2.1 FULLY AUTOMATED INSTRUMENTS

7.2.2 SEMI-AUTOMATED INSTRUMENTS

7.3 REAGENTS AND KITS

7.4 SERVICES AND SOFTWARES

8 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

8.2.1 REAL-TIME PCR

8.2.2 DIGITAL PCR

8.2.3 REVERSE TRANSCRIPTASE PCR

8.2.4 QUANTITATIVE FLUORESCENT PCR

8.2.5 DIRECT LINEAR ANALYSIS

8.2.6 COLD PCR

8.3 NEXT GENERATION SEQUENCING (NGS)

8.4 CYTOGENETICS

8.5 CAPILLARY ELECTROPHORESIS

8.6 IN SITU HYBRIDIZATION (ISH OR FISH)

8.7 MOLECULAR IMAGING

8.7.1 OPTICAL IMAGING

8.7.2 FDG-PET

8.8 MASS SPECTROMETRY (MS)

8.9 CHIPS AND MICROARRAY

8.1 OTHERS

9 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 INFECTIOUS DISEASES

9.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.2.2 NEXT GENERATION SEQUENCING (NGS)

9.2.3 CYTOGENETICS

9.2.4 CAPILLARY ELECTROPHORESIS

9.2.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.2.6 MOLECULAR IMAGING

9.2.7 MASS SPECTROMETRY (MS)

9.2.8 CHIPS AND MICROARRAY

9.2.9 OTHERS

9.3 MICROBIOLOGY

9.3.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.3.2 NEXT GENERATION SEQUENCING (NGS)

9.3.3 CYTOGENETICS

9.3.4 CAPILLARY ELECTROPHORESIS

9.3.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.3.6 MOLECULAR IMAGING

9.3.7 MASS SPECTROMETRY (MS)

9.3.8 CHIPS AND MICROARRAY

9.3.9 OTHERS

9.4 BLOOD SCREENING

9.4.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.4.2 NEXT GENERATION SEQUENCING (NGS)

9.4.3 CYTOGENETICS

9.4.4 CAPILLARY ELECTROPHORESIS

9.4.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.4.6 MOLECULAR IMAGING

9.4.7 MASS SPECTROMETRY (MS)

9.4.8 CHIPS AND MICROARRAY

9.4.9 OTHERS

9.5 ONCOLOGY

9.5.1 ONCOLOGY, BY CANCER TYPE

9.5.1.1 BREAST CANCER

9.5.1.2 COLORECTAL CANCER

9.5.1.3 LUNG CANCER

9.5.1.4 PROSTATE CANCER

9.5.1.5 OTHERS

9.5.2 ONCOLOGY, BY TECHNOLOGY

9.5.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.5.2.2 NEXT GENERATION SEQUENCING (NGS)

9.5.2.3 CYTOGENETICS

9.5.2.4 CAPILLARY ELECTROPHORESIS

9.5.2.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.5.2.6 MOLECULAR IMAGING

9.5.2.7 MASS SPECTROMETRY (MS)

9.5.2.8 CHIPS AND MICROARRAY

9.5.2.9 OTHERS

9.6 TISSUE TYPING

9.6.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.6.2 NEXT GENERATION SEQUENCING (NGS)

9.6.3 CYTOGENETICS

9.6.4 CAPILLARY ELECTROPHORESIS

9.6.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.6.6 MOLECULAR IMAGING

9.6.7 MASS SPECTROMETRY (MS)

9.6.8 CHIPS AND MICROARRAY

9.6.9 OTHERS

9.7 PHARMACOGENOMICS

9.7.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.7.2 NEXT GENERATION SEQUENCING (NGS)

9.7.3 CYTOGENETICS

9.7.4 CAPILLARY ELECTROPHORESIS

9.7.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.7.6 MOLECULAR IMAGING

9.7.7 MASS SPECTROMETRY (MS)

9.7.8 CHIPS AND MICROARRAY

9.7.9 OTHERS

9.8 PRENATAL TESTS

9.8.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.8.2 NEXT GENERATION SEQUENCING (NGS)

9.8.3 CYTOGENETICS

9.8.4 CAPILLARY ELECTROPHORESIS

9.8.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.8.6 MOLECULAR IMAGING

9.8.7 MASS SPECTROMETRY (MS)

9.8.8 CHIPS AND MICROARRAY

9.8.9 OTHERS

9.9 NEUROLOGICAL DISEASES

9.9.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.9.2 NEXT GENERATION SEQUENCING (NGS)

9.9.3 CYTOGENETICS

9.9.4 CAPILLARY ELECTROPHORESIS

9.9.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.9.6 MOLECULAR IMAGING

9.9.7 MASS SPECTROMETRY (MS)

9.9.8 CHIPS AND MICROARRAY

9.9.9 OTHERS

9.1 CARDIOVASCULAR DISEASES

9.10.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.10.2 NEXT GENERATION SEQUENCING (NGS)

9.10.3 CYTOGENETICS

9.10.4 CAPILLARY ELECTROPHORESIS

9.10.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.10.6 MOLECULAR IMAGING

9.10.7 MASS SPECTROMETRY (MS)

9.10.8 CHIPS AND MICROARRAY

9.10.9 OTHERS

9.11 OTHERS

9.11.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS

9.11.2 NEXT GENERATION SEQUENCING (NGS)

9.11.3 CYTOGENETICS

9.11.4 CAPILLARY ELECTROPHORESIS

9.11.5 IN SITU HYBRIDIZATION (ISH OR FISH)

9.11.6 MOLECULAR IMAGING

9.11.7 MASS SPECTROMETRY (MS)

9.11.8 CHIPS AND MICROARRAY

9.11.9 OTHERS

10 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY END USER

10.1 OVERVIEW

10.2 CLINICAL LABORATORIES

10.3 HOSPITAL

10.4 ACADEMICS

11 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY REGION

11.1 EUROPE

11.1.1 GERMANY

11.1.2 FRANCE

11.1.3 ITALY

11.1.4 RUSSIA

11.1.5 U.K.

11.1.6 SPAIN

11.1.7 TURKEY

11.1.8 SWITZERLAND

11.1.9 BELGIUM

11.1.10 NETHERLANDS

11.1.11 REST OF EUROPE

12 EUROPE MOLECULAR DIAGNOSTICS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT

14 COMPANY PROFILES

14.1 ABBOTT LABORATORIES

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 F. HOFFMANN-LA ROCHE LTD

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 ILLUMINA, INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 HOLOGIC, INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 BIOMÉRIEUX SA

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 REVENUE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 AGILENT TECHNOLOGIES, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.7 BD

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENTS

14.8 BECKMAN COULTER, INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BIO-RAD LABORATORIES, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENTS

14.1 CEPHEID

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 GENMARK DIAGNOSTICS, INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 IMMUCOR

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENT

14.13 LIFE TECHNOLOGIES

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 LUMINEX CORPORATION

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

14.15 MERRIDIAN BIOSCIENCE

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENTS

14.16 MYRIAD GENETICS, INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENTS

14.17 QIAGEN

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENTS

14.18 QUIDEL CORPORATION

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENT

14.19 SIEMENS HEALTHCARE GMBH

14.19.1 COMPANY SNAPSHOT

14.19.2 REVENUE ANALYSIS

14.19.3 PRODUCT PORTFOLIO

14.19.4 RECENT DEVELOPMENTS

14.2 THERMO FISHER SCIENTIFIC INC.

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表のリスト

LIST OF TABLES 

TABLE 1 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 2 EUROPE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 EUROPE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 4 EUROPE REAGENTS AND KITS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE SERVICES AND SOFTWARES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 7 EUROPE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 EUROPE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 9 EUROPE NEXT GENERATION SEQUENCING (NGS) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE CYTOGENETICS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE CAPILLARY ELECTROPHORESIS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE INS SITU HYBRIDIZATION (ISH OR FISH) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 EUROPE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 15 EUROPE MASS SPECTROMETRY (MS) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE CHIPS AND MICROARRAY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 21 EUROPE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 23 EUROPE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 25 EUROPE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 27 EUROPE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 28 EUROPE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 30 EUROPE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 32 EUROPE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 EUROPE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 34 EUROPE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 36 EUROPE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 38 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 40 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 41 EUROPE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 EUROPE HOSPITAL IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE ACADEMICS IN MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 45 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 46 EUROPE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 47 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 48 EUROPE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 49 EUROPE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 50 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 EUROPE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 52 EUROPE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 EUROPE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 EUROPE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 EUROPE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 EUROPE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 EUROPE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 58 EUROPE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 EUROPE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 EUROPE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 61 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 62 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 63 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 64 GERMANY INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 65 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 66 GERMANY POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 67 GERMANY MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 68 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 69 GERMANY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 70 GERMANY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 71 GERMANY PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 72 GERMANY MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 GERMANY PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 74 GERMANY TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 GERMANY BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 76 GERMANY CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 GERMANY NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 78 GERMANY INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 79 GERMANY OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 80 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 82 FRANCE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 83 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 84 FRANCE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 85 FRANCE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 86 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 FRANCE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 88 FRANCE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 89 FRANCE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 90 FRANCE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 91 FRANCE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 92 FRANCE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 93 FRANCE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 94 FRANCE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 95 FRANCE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 96 FRANCE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 FRANCE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 98 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 ITALY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 100 ITALY INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 101 ITALY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 102 ITALY POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 103 ITALY MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 104 ITALY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 ITALY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 106 ITALY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 ITALY PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 108 ITALY MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 109 ITALY PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 110 ITALY TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 111 ITALY BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 112 ITALY CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 113 ITALY NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 114 ITALY INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 115 ITALY OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 116 ITALY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 117 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 118 RUSSIA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 119 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 120 RUSSIA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 121 RUSSIA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 122 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 123 RUSSIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 124 RUSSIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 125 RUSSIA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 126 RUSSIA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 RUSSIA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 128 RUSSIA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 129 RUSSIA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 130 RUSSIA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 131 RUSSIA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 132 RUSSIA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 133 RUSSIA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 134 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 135 U.K. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 136 U.K. INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 137 U.K. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 138 U.K. POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 139 U.K. MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 140 U.K. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 141 U.K. ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 142 U.K. ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 143 U.K. PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 144 U.K. MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 145 U.K. PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 146 U.K. TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 147 U.K. BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 148 U.K. CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 149 U.K. NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 150 U.K. INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 151 U.K. OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 152 U.K. MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 153 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 154 SPAIN INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 155 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 156 SPAIN POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 157 SPAIN MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 158 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 159 SPAIN ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 160 SPAIN ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 161 SPAIN PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 162 SPAIN MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 163 SPAIN PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 164 SPAIN TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 165 SPAIN BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 166 SPAIN CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 167 SPAIN NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 168 SPAIN INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 169 SPAIN OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 170 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 171 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 172 TURKEY INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 173 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 174 TURKEY POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 175 TURKEY MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 176 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 177 TURKEY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 178 TURKEY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 179 TURKEY PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 180 TURKEY MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 181 TURKEY PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 182 TURKEY TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 183 TURKEY BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 184 TURKEY CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 185 TURKEY NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 186 TURKEY INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 187 TURKEY OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 188 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 189 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 190 SWITZERLAND INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 191 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 192 SWITZERLAND POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 193 SWITZERLAND MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 194 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 195 SWITZERLAND ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 196 SWITZERLAND ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 197 SWITZERLAND PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 198 SWITZERLAND MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 199 SWITZERLAND PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 200 SWITZERLAND TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 201 SWITZERLAND BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 202 SWITZERLAND CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 203 SWITZERLAND NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 204 SWITZERLAND INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 205 SWITZERLAND OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 206 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 207 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 208 BELGIUM INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 209 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 210 BELGIUM POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 211 BELGIUM MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 212 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 213 BELGIUM ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 214 BELGIUM ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 215 BELGIUM PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 216 BELGIUM MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 217 BELGIUM PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 218 BELGIUM TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 219 BELGIUM BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 220 BELGIUM CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 221 BELGIUM NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 222 BELGIUM INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 223 BELGIUM OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 224 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 225 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 226 NETHERLANDS INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 227 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 228 NETHERLANDS POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 229 NETHERLANDS MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 230 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 231 NETHERLANDS ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 232 NETHERLANDS ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 233 NETHERLANDS PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 234 NETHERLANDS MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 235 NETHERLANDS PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 236 NETHERLANDS TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 237 NETHERLANDS BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 238 NETHERLANDS CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 239 NETHERLANDS NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 240 NETHERLANDS INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 241 NETHERLANDS OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 242 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 243 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

 

図表一覧

LIST OF FIGURES 

FIGURE 1 EUROPE MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 EUROPE MOLECULAR DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE MOLECULAR DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE MOLECULAR DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE MOLECULAR DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE MOLECULAR DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE MOLECULAR DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE MOLECULAR DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE MOLECULAR DIAGNOSTICS MARKET AND GROWING WITH THE HIGHEST SHARE IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 11 THE INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER IS EXPECTED TO DRIVE THE EUROPE MOLECULAR DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MOLECULAR DIAGNOSTICS MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE MOLECULAR DIAGNOSTICS MARKET

FIGURE 14 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020

FIGURE 15 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020

FIGURE 16 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020

FIGURE 17 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020

FIGURE 18 EUROPE MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 19 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 20 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 21 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 22 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028)

FIGURE 23 EUROPE MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)

 

 

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。